BioItalia ApS: Financial statements 2023
CVR: 41304413
Source: annual report 2023, Danish Business Authority
01/10/2022 – 30/09/2023
BioItalia ApS (CVR 41304413) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 2,808 and a net result of DKK -9,181 compared with DKK -7,664 the year before. That is a decrease of 18.7% compared with the year before. Equity in the 2023 report amounted to DKK -14,511.
- Gross Profit
- DKK 2,808
- Profit/Loss
- DKK -9,181
- Equity
- DKK -14,511
- Total Assets
- DKK 35,214
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 3 t. | -9 t. | -15 t. | 0 |
| 2022 | - | 3 t. | -8 t. | -5 t. | 0 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
BioItalia ApS has published its annual report for 2022. Gross profit came to DKK 3,453, and the net result was DKK -7,664.
About BioItalia ApS
BioItalia ApS is a Danish company of the type Anpartsselskab based in Viborg, founded in 2020. The company is registered under the industry Detailhandel med drikkevarer. The company was previously named Økovine ApS. The management consists of Kurt Andie Bødker. The company is owned by LOWIN ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 6,389 and a net result of DKK -3,931 compared with DKK -7,430 the year before. Equity in the 2025 report amounted to DKK -25,871.